EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline

Lilliam Ambroggio, Jillian Cotter, Matthew Hall, Daniel J Shapiro, Susan C Lipsett, Adam L Hersh, Samir S Shah, Thomas V Brogan, Jeffrey S Gerber, Derek J Williams, Anne J Blaschke, Jonathan D Cogen und 1 weitere

Clinical Infectious Diseases · 30.11.2023 · 77 (11) · 1604-1611

DOI: 10.1093/cid/ciad385 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 23.06.2023. Verfasst von Lilliam Ambroggio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sections of Emergency Medicine and Hospital Medicine, Children's Hospital Colorado, Department of Pediatrics, University of Colorado, Aurora, Colorad…. Hauptthemen laut MEDLINE: Pneumonia, Communicable Diseases, COVID-19, Community-Acquired Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAID NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Incomplete uptake of guidelines can lead to nonstandardized care, increased expenditures, and adverse clinical outcomes. The objective of this study was to evaluate the impact of the 2011 Pediatric Infectious Diseases Society and Infectious Diseases Society of America (PIDS/IDSA) pediatric community-acquired pneumonia (CAP) guideline that emphasized aminopenicillin use and de-emphasized the use of chest radiographs (CXRs) in certain populations.

Methods

This quasi-experimental study queried a national administrative database of children's hospitals to identify children aged 3 months–18 years with CAP who visited 1 of 28 participating hospitals from 2009 to 2021. PIDS/IDSA pediatric CAP guideline recommendations regarding antibiotic therapy, diagnostic testing, and imaging were evaluated. Segmented regression interrupted time series was used to measure guideline-concordant practices with interruptions for guideline publication and the Coronavirus Disease 2019 (COVID-19) pandemic.

Results

Of 315 384 children with CAP, 71 804 (22.8%) were hospitalized. Among hospitalized children, there was a decrease in blood culture performance (0.5% per quarter) and increase in aminopenicillin prescribing (1.1% per quarter). Among children discharged from the emergency department (ED), there was an increase in aminopenicillin prescription (0.45% per quarter), whereas the rate of obtaining CXRs declined (0.12% per quarter). However, use of CXRs rebounded during the COVID-19 pandemic (increase of 1.56% per quarter). Hospital length of stay, ED revisit rates, and hospital readmission rates remained stable.

Conclusions

Guideline publication was associated with an increase of aminopenicillin prescribing. However, rates of diagnostic testing did not materially change, suggesting the need to consider implementation strategies to meaningfully change clinical practice for children with CAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumoniaCommunicable DiseasesCOVID-19Community-Acquired InfectionsChildHumansPandemicsAnti-Bacterial AgentsEmergency Service, HospitalPenicillinsGuideline AdherenceRetrospective Studies

Stichwörter der Autor:innen

antibioticsdiagnostic testingpediatricpneumonia

Substanzen

Anti-Bacterial AgentsPenicillins

Autor:innen und Institutionen

  • Sections of Emergency Medicine and Hospital Medicine, Children's Hospital Colorado, Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
  • Children's Hospital Association, Lenexa, Kansas, USA.
  • Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Departments of Pediatrics and Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Division of Hospital Medicine, Cincinnati Children's Hospital Medicine Center, Cincinnati, Ohio, USA.

Förderung

  • NCATS NIH HHS
  • NIAID NIH HHS
  • AHRQ HHS
  • Pfizer Inc
  • National Institute of Allergy and Infectious Diseases
  • Agency for Healthcare Quality and Research
  • NIH

Zitieren

APA

Ambroggio, L., Cotter, J., Hall, M., Shapiro, D. J., Lipsett, S. C., Hersh, A. L., Shah, S. S., Brogan, T. V., Gerber, J. S., Williams, D. J., Blaschke, A. J., Cogen, J. D., & Neuman, M. I. (2023). Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline. Clinical Infectious Diseases, 77(11), 1604-1611. https://doi.org/10.1093/cid/ciad385

Vancouver

Ambroggio L, Cotter J, Hall M, Shapiro DJ, Lipsett SC, Hersh AL, et al. Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline. Clinical Infectious Diseases. 2023;77(11):1604-1611. doi:10.1093/cid/ciad385

BibTeX
@article{Ambroggio2023,
  author = {Ambroggio, Lilliam and Cotter, Jillian and Hall, Matthew and Shapiro, Daniel J and Lipsett, Susan C and Hersh, Adam L and Shah, Samir S and Brogan, Thomas V and Gerber, Jeffrey S and Williams, Derek J and Blaschke, Anne J and Cogen, Jonathan D and Neuman, Mark I},
  title = {Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {11},
  pages = {1604--1611},
  doi = {10.1093/cid/ciad385}
}
Kostenlos starten →